FDA Warning Letter — BP

Case 520699 — FEI 3013359917

The FDA took a Warning Letter action against BP on Mar 23, 2017 (Washington, DC). The action was issued by CTP and concerns tobacco products.

Action Details

Facility
BP
Date
Mar 23, 2017
Fiscal Year
2017
Product Type
Tobacco
Center
CTP
Location
Washington, DC (United States)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.